Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
O’Donnell A, McParlin C, Robson SC, et al. Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment. Southampton (UK): NIHR Journals Library; 2016 Oct. (Health Technology Assessment, No. 20.74.)
Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment.
Show detailsDomain | Description | Review authors’ judgement |
---|---|---|
Sequence generation | Describe the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether or not it should produce comparable groups | Was the allocation sequence adequately generated? |
Allocation concealment | Describe the method used to conceal the allocation sequence in sufficient detail to determine whether or not intervention allocations could have been foreseen in advance of, or during, enrolment | Was allocation adequately concealed? |
Blinding of participants, personnel and outcome assessors Assessments should be made for each main outcome (or class of outcomes) | Describe all measures used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. Provide any information relating to whether the intended blinding was effective | Was knowledge of the allocated intervention adequately prevented during the study? |
Incomplete outcome data Assessments should be made for each main outcome (or class of outcomes) | Describe the completeness of outcome data for each main outcome, including attrition and exclusions from the analysis. State whether attrition and exclusions were reported, the numbers in each intervention group (compared with total randomised participants), reasons for attrition/exclusions where reported, and any reinclusions in analyses performed by the review authors | Were incomplete outcome data adequately addressed? |
Selective outcome reporting | State how the possibility of selective outcome reporting was examined by the review authors, and what was found | Are reports of the study free of suggestion of selective outcome reporting? |
Other sources of bias | State any important concerns about bias not addressed in the other domains in the tool If particular questions/entries were pre-specified in the review’s protocol, responses should be provided for each question/entry | Was the study apparently free of other problems that could put it at a high risk of bias? |
Possible approach for summary assessments outcome (across domains) within and across studies
Risk of bias | Interpretation | Within a study | Across studies |
---|---|---|---|
Low risk of bias | Plausible bias unlikely to seriously alter the results | Low risk of bias for all key domains | Most information is from studies at low risk of bias |
Unclear risk of bias | Plausible bias that raises some doubt about the results | Unclear risk of bias for one or more key domains | Most information is from studies at low or unclear risk of bias |
High risk of bias | Plausible bias that seriously weakens confidence in the results | High risk of bias for one or more key domains | The proportion of information from studies at high risk of bias is sufficient to affect the interpretation of the results |
Criteria for judging risk of bias in the ‘risk of bias’ assessment tool
Sequence generation | |
---|---|
Was the allocation sequence adequately generated? [Short form: Adequate sequence generation?] | |
Criteria for a judgement of ‘YES’ (i.e. low risk of bias) | The investigators describe a random component in the sequence generation process such as:
|
Criteria for the judgement of ‘NO’ (i.e. high risk of bias) | The investigators describe a non-random component in the sequence generation process. Usually, the description would involve some systematic, non-random approach, for example:
|
Criteria for the judgement of ‘UNCLEAR’ (uncertain risk of bias) | Insufficient information about the sequence generation process to permit judgement of ‘YES’ or ‘NO’ |
Allocation concealment | |
Was allocation adequately concealed? [Short form: Allocation concealment?] | |
Criteria for a judgement of ‘YES’ (i.e. low risk of bias) | Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent method, was used to conceal allocation:
|
Criteria for the judgement of ‘NO’ (i.e. high risk of bias) | Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation based on:
|
Criteria for the judgement of ‘UNCLEAR’ (uncertain risk of bias) | Insufficient information to permit judgement of ‘YES’ or ‘NO’. This is usually the case if the method of concealment is not described or not described in sufficient detail to allow a definite judgement; for example, if the use of assignment envelopes is described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed |
Blinding of participants, personnel and outcome assessors | |
Was knowledge of the allocated interventions adequately prevented during the study? [Short form: Blinding?] | |
Criteria for a judgement of ‘YES’ (i.e. low risk of bias) | Any one of the following:
|
Criteria for the judgement of ‘NO’ (i.e. high risk of bias) | Any one of the following:
|
Criteria for the judgement of ‘UNCLEAR’ (uncertain risk of bias) | Any one of the following:
|
Incomplete outcome data | |
Were incomplete outcome data adequately addressed? [Short form: Incomplete outcome data addressed?] | |
Criteria for a judgement of ‘YES’ (i.e. low risk of bias) | Any one of the following:
|
Criteria for the judgement of ‘NO’ (i.e. high risk of bias) | Any one of the following:
|
Criteria for the judgement of ‘UNCLEAR’ (uncertain risk of bias) | Any one of the following:
|
Selective outcome reporting | |
Are reports of the study free of suggestion of selective outcome reporting? [Short form: Free of selective reporting?] | |
Criteria for a judgement of ‘YES’ (i.e. low risk of bias) | Any of the following:
|
Criteria for the judgement of ‘NO’ (i.e. high risk of bias) | Any one of the following:
|
Criteria for the judgement of ‘UNCLEAR’ (uncertain risk of bias) | Insufficient information to permit judgement of ‘YES’ or ‘NO’. It is likely that the majority of studies will fall into this category |
Other potential threats to validity | |
Was the study apparently free of other problems that could put it at a risk of bias? [Short form: Free of other bias?] | |
Criteria for a judgement of ‘YES’ (i.e. low risk of bias) | The study appears to be free of other sources of bias |
Criteria for the judgement of ‘NO’ (i.e. high risk of bias) | There is at least one important risk of bias. For example, the study:
|
Criteria for the judgement of ‘UNCLEAR’ (uncertain risk of bias) | There may be a risk of bias, but there is either:
|
- a
Minimisation may be implemented without a random element, and this is considered to be equivalent to being random.
- Risk of bias for randomised controlled trials - Treatments for hyperemesis gravi...Risk of bias for randomised controlled trials - Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment
- Participant results newsletter - Cost and Outcome of BehaviouRal Activation (COB...Participant results newsletter - Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive–behavioural therapy for depression
- Data abstraction tables: diagnostic review - Echocardiography in newly diagnosed...Data abstraction tables: diagnostic review - Echocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation
- Scientific summary - The second Randomised Evaluation of the Effectiveness, cost...Scientific summary - The second Randomised Evaluation of the Effectiveness, cost-effectiveness and Acceptability of Computerised Therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trial
- References - Feasibility of in-home monitoring for people with glaucoma: the I-T...References - Feasibility of in-home monitoring for people with glaucoma: the I-TRAC mixed-methods study
Your browsing activity is empty.
Activity recording is turned off.
See more...